CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will present at the Jefferies 2011 Global Healthcare Conference in London. Harvey J. Berger, M.D., chairman and chief executive officer, will provide an overview of the Company’s robust oncology pipeline and progress on its three lead compounds on Wednesday, September 28 at 8:40 a.m. local time.
